The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

被引：3
|
作者：
Dal Bello, Maria Giovanna [1 ]
Filiberti, Rosangela [2 ]
Rijavec, Erka [1 ]
Genova, Carlo [1 ]
Barletta, Giulia [1 ]
Rossi, Giovanni [1 ]
Biello, Federica [1 ]
Distefano, Roberta [1 ]
Orengo, Anna Maria [1 ]
Alama, Angela [1 ]
Coco, Simona [1 ]
Vanni, Irene [2 ]
Mussap, Michele [1 ]
Grossi, Francesco [1 ]
机构：
[1] Natl Inst Canc Res, San Martino Hosp, Lung Canc Unit, Genoa, Italy
[2] Natl Inst Canc Res, San Martino Hosp, Clin Epidemiol, Genoa, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
CYFRA; 21-1; predictive factors; tumor markers; CEA;
D O I：
10.1016/j.jtho.2016.11.1119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-067
引用
收藏
页码：S827 / S828
页数：2
相关论文
共 50 条
  • [1] The relevance of CEA and CYFRA21-1 as predictive factors in nivolumab treated advanced non-small cell lung cancer (NSCLC) patients
    Dal Bello, M. G.
    Filiberti, R. A.
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Rossi, G.
    Biello, F.
    Distefano, R.
    Orengo, A. M.
    Alama, A.
    Coco, S.
    Vanni, I.
    Tagliamento, M.
    Mussap, M.
    Grossi, F.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 161 - 161
  • [2] The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
    Dal Bello, M. G.
    Filiberti, R. A.
    Alama, A.
    Orengo, A. M.
    Mussap, M.
    Coco, S.
    Vanni, I.
    Boccardo, S.
    Rijavec, E.
    Genova, C.
    Biello, F.
    Barletta, G.
    Rossi, G.
    Tagliamento, M.
    Maggioni, C.
    Grossi, F.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [3] The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
    M. G. Dal Bello
    R. A. Filiberti
    A. Alama
    A. M. Orengo
    M. Mussap
    S. Coco
    I. Vanni
    S. Boccardo
    E. Rijavec
    C. Genova
    F. Biello
    G. Barletta
    G. Rossi
    M. Tagliamento
    C. Maggioni
    F. Grossi
    [J]. Journal of Translational Medicine, 17
  • [4] Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-small Cell Lung Cancer Patients
    Sone, Kazuki
    Oguri, Tetsuya
    Ito, Keima
    Kitamura, Yuki
    Inoue, Yoshitsugu
    Takeuchi, Akira
    Fukuda, Satoshi
    Takakuwa, Osamu
    Maeno, Ken
    Asano, Takamitsu
    Kanemitsu, Yoshihiro
    Ohkubo, Hirotsugu
    Takemura, Masaya
    Ito, Yutaka
    Niimi, Akio
    [J]. ANTICANCER RESEARCH, 2017, 37 (09) : 5125 - 5131
  • [5] Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
    Jung, Minkyu
    Kim, Se Hyun
    Lee, Young Joo
    Hong, Soojung
    Kang, Young Ae
    Kim, Se Kyu
    Chang, Joon
    Rha, Sun Young
    Kim, Joo Hang
    Kim, Dae Joon
    Cho, Byoung Chul
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (04) : 685 - 693
  • [6] Effect of gefitinib on serum EGFR and CYFRA21-1 in patients with advanced non-small cell lung cancer
    Ren, Hui
    Hu, Yang
    Xie, Tao
    Jin, Caibao
    Hu, Yanping
    Yang, Bin
    [J]. ONCOLOGY LETTERS, 2019, 18 (04) : 4167 - 4175
  • [7] Analysis of predictive factors in non-small cell lung cancer patients treated with nivolumab
    Azuma, K.
    Tamiya, A.
    Adachi, Y.
    Enomoto, T.
    Kouno, S.
    Taniguchi, Y.
    Saijo, N.
    Okishio, K.
    Atagi, S.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 30 - 30
  • [8] CEA, CYFRA21-1 AND SCC IN NON-SMALL-CELL LUNG-CANCER
    MORO, D
    VILLEMAIN, D
    VUILLEZ, JP
    DELORD, CA
    BRAMBILLA, C
    [J]. LUNG CANCER, 1995, 13 (02) : 169 - 176
  • [9] Is CYFRA 21-1 and CEA estimation helpful in preoperative assessment of non-small cell lung cancer (NSCLC) patients?
    Monika, Szturmowicz
    Ski, Rudzi P.
    Kacprzak, A.
    Langfort, R.
    Demkow, U.
    Bestry, I
    Orlowski, T.
    [J]. TUMOR BIOLOGY, 2006, 27 : 79 - 79
  • [10] SERUM CEA AND CYFRA RESPONSES AS PROGNOSTIC FACTORS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    Yoshimura, Akihiro
    Hasegawa, Koichi
    Omura, Ayaka
    Hamashima, Ryosuke
    Uda, Sayaka
    Tsuji, Taisuke
    Shiotsu, Shinsuke
    Yuba, Tatsuya
    Takumi, Chieko
    Hiraoka, Noriya
    [J]. RESPIROLOGY, 2017, 22 : 74 - 74
12345